RxDoctor Payments Data

Courtney Greene

Nurse Practitioner · Kinston, NCNPI 1114447232

Payments from drug & device makers

$2,896in general payments, 2019–2025

Across 183 payments — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$700
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$505
  • E.r. Squibb & Sons, L.L.C.$284
  • Johnson & Johnson$249
  • Merck$231
  • AstraZeneca$155
  • plus $770 from 12 others

What the payments were for

  • Food & beverage$2,883100%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,896 in reported general payments places this provider in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$10,172
Medicare patients
122
Services billed
272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban363$308,064
EntrestoSacubitril/Valsartan165$148,615
Repatha SureclickEvolocumab158$103,579
FarxigaDapagliflozin Propanediol88$62,489
XareltoRivaroxaban55$39,584
JardianceEmpagliflozin47$32,738
BrilintaTicagrelor17$9,680
Metoprolol Succinate649$6,610
Torsemide457$5,551
Rosuvastatin Calcium457$4,553
Isosorbide Dinit-HydralazineIsosorbide Dinit/Hydralazine21$3,903
Atorvastatin Calcium436$3,229
Potassium Chloride122$2,749
Flecainide Acetate72$2,044
Ranolazine ErRanolazine26$1,964

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$43$308,064363 claims
NovartisEntresto$700$148,615165 claims
AstraZenecaFarxiga, Brilinta$155$72,169105 claims
Johnson & JohnsonXarelto$249$39,58455 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Kinston

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →